Coya Therapeutics Inc. (COYA)
NASDAQ: COYA
· Real-Time Price · USD
5.31
-0.25 (-4.50%)
At close: Sep 25, 2025, 3:59 PM
5.31
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-4.50% (1D)
| Bid | 5.25 |
| Market Cap | 88.81M |
| Revenue (ttm) | 423.45K |
| Net Income (ttm) | -6.11B |
| EPS (ttm) | -1.24 |
| PE Ratio (ttm) | -4.28 |
| Forward PE | -2.79 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.69 |
| Volume | 33,919 |
| Avg. Volume (20D) | 99,237.6 |
| Open | 5.50 |
| Previous Close | 5.56 |
| Day's Range | 5.30 - 5.55 |
| 52-Week Range | 4.65 - 10.24 |
| Beta | 0.27 |
| Ex-Dividend Date | n/a |
About COYA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COYA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COYA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCoya Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+7.2%
Coya Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
11 months ago
-27.67%
Coya Therapeutics shares are trading lower. The company announced results from the placebo-controlled Phase 2 clinical trial of LD IL-2 in patients with mild to moderate Alzheimer's Disease.
